Clinical implications of the coexpression of SRC1 and NANOG in HER-2-overexpressing breast cancers
Chengyan Jin,1 Xingyi Zhang,1 Mei Sun,2 Yifan Zhang,1 Guangxin Zhang,1 Bin Wang1 1Department of Thoracic Surgery, 2Department of Pathology, The Second Affiliated Hospital of Jilin University, Changchun, People’s Republic of China Objective: Given the lack of clarity on the expression sta...
Main Authors: | Jin CY, Zhang XY, Sun M, Zhang YF, Zhang GX, Wang B |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-09-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/clinical-implications-of-the-coexpression-of-src1-and-nanog-in-her-2-o-peer-reviewed-article-OTT |
Similar Items
-
Prognostic significance of NANOG expression in solid tumors: a meta-analysis
by: Zhao LQ, et al.
Published: (2018-09-01) -
Combination of Doxorubicin and Berberine Generated Synergistic Anticancer Effect on Breast Cancer Cells Through Down-regulation of Nanog and miRNA-21 Gene Expression
by: Samia A. Ebeid, et al.
Published: (2020-07-01) -
Clinicopathological and prognostic significance of Nanog expression in non-small cell lung cancer: a meta-analysis
by: Huang G, et al.
Published: (2019-05-01) -
Combination of SIRT1 and Src overexpression suggests poor prognosis in luminal breast cancer
by: Tan J, et al.
Published: (2018-04-01) -
Nanog Signaling Mediates Radioresistance in ALDH-Positive Breast Cancer Cells
by: Mozhgan Dehghan Harati, et al.
Published: (2019-03-01)